Solid Biosciences Inc.

3.40
-0.29 (-7.86%)
At close: Apr 03, 2025, 3:59 PM
3.37
-1.02%
After-hours: Apr 03, 2025, 06:41 PM EDT

Solid Biosciences Statistics

Share Statistics

Solid Biosciences has 77.49M shares outstanding. The number of shares has increased by 101.91% in one year.

Shares Outstanding 77.49M
Shares Change (YoY) 101.91%
Shares Change (QoQ) 93.95%
Owned by Institutions (%) 0%
Shares Floating 67.1M
Failed to Deliver (FTD) Shares 25.38K
FTD / Avg. Volume 1.02%

Short Selling Information

The latest short interest is 2.33M, so 5.84% of the outstanding shares have been sold short.

Short Interest 2.33M
Short % of Shares Out 5.84%
Short % of Float 7.13%
Short Ratio (days to cover) 4.23

Valuation Ratios

The PE ratio is -1.31 and the forward PE ratio is -1.14. Solid Biosciences's PEG ratio is 0.04.

PE Ratio -1.31
Forward PE -1.14
PS Ratio 0
Forward PS 0.8
PB Ratio 1.19
P/FCF Ratio -1.62
PEG Ratio 0.04
Financial Ratio History

Enterprise Valuation

Currently the Enterprise Value (EV) is not available for Solid Biosciences.

EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 5.2, with a Debt / Equity ratio of 0.18.

Current Ratio 5.2
Quick Ratio 5.2
Debt / Equity 0.18
Debt / EBITDA -0.19
Debt / FCF -0.24
Interest Coverage 381.55

Financial Efficiency

Return on Equity is n/a and Return on Invested Capital is n/a.

Return on Equity n/a
Return on Assets n/a
Return on Invested Capital n/a
Revenue Per Employee $0
Profits Per Employee $-1.25M
Employee Count 100
Asset Turnover 0
Inventory Turnover n/a

Taxes

Income Tax 0
Effective Tax Rate 0%

Stock Price Statistics

The stock price has increased by -70.45% in the last 52 weeks. The beta is 1.98, so Solid Biosciences's price volatility has been higher than the market average.

Beta 1.98
52-Week Price Change -70.45%
50-Day Moving Average 4.42
200-Day Moving Average 6
Relative Strength Index (RSI) 37.09
Average Volume (20 Days) 2.49M

Income Statement

Revenue n/a
Gross Profit 0
Operating Income -129.73M
Net Income -124.7M
EBITDA -129.73M
EBIT -125.04M
Earnings Per Share (EPS) -3.06
Full Income Statement

Balance Sheet

The company has 80.23M in cash and 24.18M in debt, giving a net cash position of 56.06M.

Cash & Cash Equivalents 80.23M
Total Debt 24.18M
Net Cash 56.06M
Retained Earnings -783.45M
Total Assets 188.66M
Working Capital 127.05M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -100.01M and capital expenditures -654K, giving a free cash flow of -100.67M.

Operating Cash Flow -100.01M
Capital Expenditures -654K
Free Cash Flow -100.67M
FCF Per Share -2.47
Full Cash Flow Statement

Margins

Gross Margin n/a
Operating Margin n/a
Pretax Margin n/a
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

SLDB does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Payout Ratio n/a
Earnings Yield n/a
FCF Yield n/a
Dividend Details

Analyst Forecast

The average price target for SLDB is $15.5, which is 318.9% higher than the current price. The consensus rating is "Buy".

Price Target $15.5
Price Target Difference 318.9%
Analyst Consensus Buy
Analyst Count 10
Stock Forecasts

Stock Splits

The last stock split was on Oct 28, 2022. It was a backward split with a ratio of 1:15.

Last Split Date Oct 28, 2022
Split Type backward
Split Ratio 1:15

Scores

Altman Z-Score -4.04
Piotroski F-Score 2